Sodium-glucose Cotransporter 2 Inhibitors for Treating Diabetes Mellitus.

CMAJ Canadian Medical Association journal = journal de l'Association medicale canadienne（2017）

引用 2|浏览4

暂无评分

摘要

Sodium–glucose cotransporter 2 inhibitors (SGLT2s) are typically prescribed as a second-line agent for adults with type 2 diabetes mellitus to improve glycemic control. They reduce tubular glucose reabsorption in the proximal tubule, thereby enhancing execretion of urinary glucose. This insulin -

查看译文

关键词

SGLT2 Inhibitors,Type 2 Diabetes,Insulin Therapy,Insulin Signaling,Glucose Control

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要